How can you build up your database before your #womenshealth study is opened for recruitment? Read @ICONplc's recent #casestudy to find out https://t.co/FKaenPCGxc
Learn how to prioritise your #medicaldevices & IVD devices under the new #MDR & #IVDR in our latest @MDDIonline article https://t.co/PATWSO6Y24
@ICONplc's #meddevice experts share insights on the recent #FDA guidance re: expansion of the Abbreviated 510(k) program in their recent blog post https://t.co/x9qwPLBjZG
Join @ICONplc's expert staff for a July 17 webinar exploring solutions for overcoming #NASH#ClinicalTrial challenges & considerations. Final days to register - https://t.co/1yRMzR0Mvp
In-time, step by step, visit specific guidance reduces the time burden on staff, increases compliance and reduces protocol deviations. Contact us today to find out more: https://t.co/KGoNTVu9XK
ICON's Miranda Dollen, BSc (Hons) will be a facilitator for panel discussions at Graviton International's #PVEUROPE 2018 (May 22-23; London). Learn more: https://t.co/Ir9SpykSB0
May 24 Webinar – @ICONplc's Bill Row (Divisional Principal, #RWE) will provide insights on strategies to identify #realworlddata sets to answer your research objectives. Register today: https://t.co/lJIJkadloE
May 24 Webinar – ICON's Bill Row (Divisional Principal, RWE Solutions) will provide insights on strategies to identify real world data sets to answer your research objectives. Register today: https://t.co/b2x61JEoOq
Meet ICON's team of oncology experts at #ASCO18 to find out more about their customized process & approaches to address CAR-T specific challenges: https://t.co/lNoP6FeN6g
Join ICON’s Mike Pace at xConomy's May 16th "What's Hot in Boston Biotech" conference as he moderates a featured panel session on "Setting the Price & Value of the first U.S. Gene Therapy" - Cambridge, MA: https://t.co/C44crxgGfs
Discover this three-step approach to identifying your products with the highest commercial value, helping you prioritise your medical and IVD devices for compliance with the new MDR and IVDR https://t.co/r9tKFDP40O